◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

China Resources Pharmaceutical Group Limited (3320) Financial History

Name: China Resources Pharmaceutical Group Limited (3320) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

China Resources Pharmaceutical Group Limited (3320) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 85,600 employees. Its market capitalization is roughly CNY 30 billion. In the fiscal year ended 2025-12-31, 3320 reported CNY 269.6B in revenue and CNY 4.0B in net income.

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Interactive charts & full statements →

3320 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 269.6B	CNY 257.7B	CNY 244.7B	CNY 218.2B	—
Gross Profit	CNY 44.5B	CNY 40.7B	CNY 38.3B	CNY 33.6B	—
Operating Income (EBIT)	CNY 14.1B	CNY 13.3B	CNY 12.6B	CNY 12.4B	—
Net Income	CNY 4.0B	CNY 3.4B	CNY 3.9B	CNY 3.5B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3320 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 779M)	(CNY 1.5B)	(CNY 880M)	(CNY 813M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3320 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 285.8B	CNY 257.8B	CNY 246.8B	CNY 215.5B	—
Total Liabilities	CNY 168.4B	CNY 159.7B	CNY 153.8B	CNY 135.0B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3320 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

9273 · Koa Shoji Holdings Co.,Ltd. — $32 billion
2096 · Simcere Pharmaceutical Group Limited — $32 billion
SDZ · Sandoz Group AG — $32 billion
HLN · Haleon plc — $31 billion
0867 · China Medical System Holdings Limited — $30 billion
1513 · Livzon Pharmaceutical Group Inc. — $23 billion
6887 · Sunshine Lake Pharma Co., Ltd. — $20 billion
0512 · Grand Pharmaceutical Group Limited — $19 billion

← 3319 All “0-9” companies 3321 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.